Should CVS Health Be in Your Portfolio?

CVS Health (NYSE: CVS) has been caught in a couple of controversies over the last month. CVS was recently sued by the New York Attorney General for allegedly breaching antitrust laws. Additionally, laxatives sold by the company have been recalled after a suspected contamination of the products. This culmination of bad news and other factors has had an adverse effect on the company’s stock price as it’s currently down -10.31% for the last six months. Still, there are some investors who are loading up their bags with CVS in expectation of it charting higher for the years to come. In this article we’ll examine some of the reasons why,

→ Continue reading at Entrepreneur

More from author

Related posts


Latest posts

Opinion: Carbon capture is a crucial tool in California’s climate plan

California is leading the nation and much of the world with its ambitious effort to reduce the carbon emissions that are causing climate change.But...

Opinion: NASA shows what’s possible if we trimmed our military budget

Like many kids, I was once captivated by all things space. I took out every book on space from the school library. I did...

Survey: Most Californians support taxing wealth, other big moves to fight climate change

Three in four Californians now agree with a majority of scientists that climate change is contributing to the state’s drought and conditions that lead...